“Tissue-Engineered ‘Metastases’: Treatment of Hepatic Colon Tumors With a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist ”. 2021. Journal of Cancer Research Updates 1 (1): 69-77. https://doi.org/10.6000/1929-2279.2012.01.01.11.